SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddys Laboratories informs about press release

06 Jan 2026 Evaluate
Dr Reddys Laboratories has informed that it enclosed copies of newspaper publication in respect of notice regarding loss of share certificate(s) by the shareholders, published in Business Standard and Nava Telangana on December 31, 2025.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1267.05 4.40 (0.35%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.35
Dr. Reddys Lab 1267.05
Cipla 1397.75
Zydus Lifesciences 1085.45
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×